The Microtubule-Targeting Agents, PBOX-6 [Pyrrolobenzoxazepine 7-[(dimethylcarbamoyl) oxy]-6-(2-naphthyl) pyrrolo-[2,1-d] (1,5)-benzoxazepine] and Paclitaxel, Induce Nucleocytoplasmic Redistribution of the Peptidyl-Prolyl Isomerases, Cyclophilin A and Pin1, in Malignant Hematopoietic Cells

被引:16
作者
Bane, Fiona T. [1 ]
Bannon, John H. [1 ]
Pennington, Stephen R. [2 ,3 ]
Campaini, Giuseppe [4 ]
Williams, D. Clive [5 ]
Zisterer, Daniela M. [5 ]
Mc Gee, Margaret M. [1 ]
机构
[1] Univ Coll Dublin, Conway Inst Biomol & Biomed Res, Sch Biomol & Biomed Sci, Dublin 4, Ireland
[2] Univ Coll Dublin, Conway Inst Biomol & Biomed Res, Proteome Res Ctr, Dublin 4, Ireland
[3] Univ Coll Dublin, Sch Med & Med Sci, Dublin 4, Ireland
[4] Univ Siena, Dipartimento Farmaco Chim Tecnol, I-53100 Siena, Italy
[5] Trinity Coll Dublin, Sch Biochem & Immunol, Dublin, Ireland
关键词
MITOTIC SPINDLE CHECKPOINT; CIS-TRANS ISOMERIZATION; CANCER-CELLS; NUCLEAR-ENVELOPE; LEUKEMIA-CELLS; BREAST-CANCER; C-JUN; APOPTOSIS; PROTEINS; BCL-2;
D O I
10.1124/jpet.108.148130
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Microtubule assembly and disassembly is required for the maintenance of cell structure, mobility, and division. However, the cellular and biochemical implications of microtubule disruption are not fully understood. Using a proteomic approach, we found that the peptidyl-prolyl isomerase, cyclophilin A, was increased in plasma membrane extracts from chronic myeloid leukemia cells after microtubule disruption. In addition, we found that two peptidyl-prolyl isomerases, cyclophilin A and pin1, are overexpressed up to 10-fold in hematological malignancies compared with normal peripheral blood mononuclear cells. Although previous reports suggest that cyclophilin A is localized to the cytosol of mammalian cells, we found that cyclophilin A and pin1 are both localized to the nucleus and nuclear domains in hematopoietic cells. Microtubule disruption of hematopoietic cells caused a dramatic subcellular redistribution of cyclophilin A and pin1 from the nucleus to the cytosol and plasma membrane. We suggest that this accounts for the increased cyclophilin A at the plasma membrane of chronic myeloid leukemia cells after microtubule disruption. The subcellular redistribution of cyclophilin A and pin1 occurred in a c-Jun NH2-terminal kinase-and serine protease-dependent manner. Moreover, the altered subcellular localization of the peptidyl-prolyl isomerases occurred in a dose-and time-dependent manner after microtubule disruption and was found to correlate with G(2)/M arrest and precede induced cell death. These results suggest that the function of peptidyl-prolyl isomerases may be influenced by microtubule dynamics throughout the cell cycle, and their altered localization may be an important part of the mechanism by which microtubuledisrupting agents exert their cytostatic effects.
引用
收藏
页码:38 / 47
页数:10
相关论文
共 39 条
  • [1] Cyclophilin a peptidyl-prolyl isomerase activity promotes ZPR1 nuclear export
    Ansari, H
    Greco, G
    Luban, J
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 2002, 22 (20) : 6993 - 7003
  • [2] Prevalent overexpression of prolyl isomerase Pin1 in human cancers
    Bao, L
    Kimzey, A
    Sauter, G
    Sowadski, JM
    Lu, KP
    Wang, DG
    [J]. AMERICAN JOURNAL OF PATHOLOGY, 2004, 164 (05) : 1727 - 1737
  • [3] Microtubule-associated proteins as targets in cancer chemotherapy
    Bhat, Kumar M. R.
    Setaluri, Vijayasaradhi
    [J]. CLINICAL CANCER RESEARCH, 2007, 13 (10) : 2849 - 2854
  • [4] ISOLATION OF PLASMA MEMBRANE FRAGMENTS FROM HELA CELLS
    BOONE, CW
    FORD, LE
    BOND, HE
    STUART, DC
    LORENZ, D
    [J]. JOURNAL OF CELL BIOLOGY, 1969, 41 (02) : 378 - &
  • [5] Regulation of the tyrosine kinase Itk by the peptidyl-prolyl isomerase cyclophilin A
    Brazin, KN
    Mallis, RJ
    Fulton, DB
    Andreotti, AH
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (04) : 1899 - 1904
  • [6] Overexpressed cyclophilin A in cancer cells renders resistance to hypoxia- and cisplatin-induced cell death
    Choi, Kyu Jin
    Piao, Yu Ji
    Lim, Min Jin
    Kim, Jin Hwan
    Ha, Joohun
    Choe, Wonchae
    Kim, Sung Soo
    [J]. CANCER RESEARCH, 2007, 67 (08) : 3654 - 3662
  • [7] CEP-11004, an inhibitor of the SAPK/JNK pathway, reduces TNF-α release from lipopolysaccharide-treated cells and mice
    Ciallella, JR
    Saporito, M
    Lund, S
    Leist, M
    Hasseldam, H
    McGann, N
    Smith, CS
    Bozyczko-Coyne, D
    Flood, DG
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 2005, 515 (1-3) : 179 - 187
  • [8] Dynamics and mobility of nuclear envelope proteins in interphase and mitotic cells revealed by green fluorescent protein chimeras
    Ellenberg, J
    Lippincott-Schwartz, J
    [J]. METHODS-A COMPANION TO METHODS IN ENZYMOLOGY, 1999, 19 (03): : 362 - 372
  • [9] Clinical resistance to STI-571 cancer therapy caused by BCR-ABL gene mutation or amplification
    Gorre, ME
    Mohammed, M
    Ellwood, K
    Hsu, N
    Paquette, R
    Rao, PN
    Sawyers, CL
    [J]. SCIENCE, 2001, 293 (5531) : 876 - 880
  • [10] BubR1 is required for a sustained mitotic spindle checkpoint arrest in human cancer cells treated with tubulin-targeting pyrrolo-1,5-benzoxazepines
    Greene, Lisa M.
    Campiani, Giuseppe
    Lawler, Mark
    Williams, D. Clive
    Zisterer, Daniela M.
    [J]. MOLECULAR PHARMACOLOGY, 2008, 73 (02) : 419 - 430